Open AccessClinical Effects of T790M Mutation in EGFR Tyrosine Kinase Inhibitor Resistant NSCLC Patients
Author(s) -
Filiz Güldaval,
Ceyda Anar,
Melih Büyükşirin,
Merve Türk,
Günseli Balcı,
Mine Gayaf,
Murat Akyol,
İbrahim Onur Alıcı,
Gülru Polat,
Gülistan Karadeniz,
Aysu Ayrancı,
Fatma Demirci Üçsular,
Kadri Murat Erdoğan,
Yaşar Bekir Kutbay,
Şener Arıkan,
Özgür Batum,
Berna Kömürcüoğlu,
Sinem Ermin
Publication year - 2021
Publication title -
kocaeli tıp dergisi
Language(s) - English
Resource type - Journals
ISSN - 2147-0758
DOI - 10.5505/ktd.2021.82856
Subject(s) - t790m , tyrosine kinase inhibitor , mutation , tyrosine kinase , cancer research , resistance mutation , medicine , oncology , biology , gefitinib , polymerase chain reaction , genetics , epidermal growth factor receptor , cancer , gene , receptor , reverse transcriptase